The Securities Exchange Board of Nepal (SEBON) has approved the Initial Public Offering (IPO) proposal of OM Megashree Pharmaceuticals Limited.
The company plans to issue 6,000,000 equity shares at a par value of Rs. 100 per share, aiming to raise a total of Rs. 60 crore. The proposal was submitted to SEBON on Magh 03, 2081, and the IPO issuance will be managed by Prabhu Capital Limited.
Credit Ratings
CARE Ratings Nepal Limited (CRNL) has reaffirmed the following ratings for OM Megashree Pharmaceuticals Limited:
- CARE-NP BB- (Is): Indicates moderate default risk for timely financial obligations.
- CARE-NP BB-: For long-term bank facilities.
- CARE-NP A4: For short-term bank facilities.
About OM Megashree Pharmaceuticals Limited
Established on June 12, 2016, OM Megashree Pharmaceuticals Limited is a public limited company in Nepal. It is promoted by a group of institutional and individual investors.
The company manufactures pharmaceutical products at its plant located in Chitwan. Partial operations began on February 19, 2024, marking a significant milestone in its business journey.